These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 14660731)

  • 1. 131I dosimetry and thyroid stunning.
    Gerard SK; Park HM
    J Nucl Med; 2003 Dec; 44(12):2039-40; author reply 2040. PubMed ID: 14660731
    [No Abstract]   [Full Text] [Related]  

  • 2. Dosimetry-guided radioactive iodine treatment in patients with metastatic differentiated thyroid cancer: largest safe dose using a risk-adapted approach.
    Dorn R; Kopp J; Vogt H; Heidenreich P; Carroll RG; Gulec SA
    J Nucl Med; 2003 Mar; 44(3):451-6. PubMed ID: 12621014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metabolic therapy with radioiodine of differentiated thyroid tumor].
    Bestagno M; Campagnari G
    Minerva Med; 1986 Nov; 77(44):2113-6. PubMed ID: 3785727
    [No Abstract]   [Full Text] [Related]  

  • 4. Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer.
    Lassmann M; Luster M; Hänscheid H; Reiners C
    J Nucl Med; 2005 May; 46(5):899. PubMed ID: 15872368
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long-term results of iodine radioisotope therapy for lung metastasis of thyroid cancer].
    Tsyb AF; Drozdovskiĭ BI; Proshin VV
    Vopr Onkol; 1996; 42(3):73-5. PubMed ID: 8801748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determining the activities of 131I with dose-rate constraint method for the treatment of differentiated thyroid carcinoma with diffuse pulmonary metastases].
    Liu B; Zeng Y; Wang JT; Zhao Z; Mu D; Kuang AR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 May; 41(3):513-7. PubMed ID: 20629335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood and bone marrow dosimetry in radioiodine therapy of thyroid cancer.
    Sgouros G
    J Nucl Med; 2005 May; 46(5):899-900; author reply 901. PubMed ID: 15872367
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood and bone marrow dosimetry in radioiodine therapy of differentiated thyroid cancer after stimulation with rhTSH.
    Lassmann M; Hänscheid H; Reiners C; Thomas SR
    J Nucl Med; 2005 May; 46(5):900-1; author reply 901. PubMed ID: 15872369
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of distant metastases of thyroid cancer using 131I].
    Drozdovskiĭ BIa; Proshin VV
    Med Radiol (Mosk); 1986 Jul; 31(7):18-20. PubMed ID: 3736381
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimized 124I PET dosimetry protocol for radioiodine therapy of differentiated thyroid cancer.
    Jentzen W; Freudenberg L; Eising EG; Sonnenschein W; Knust J; Bockisch A
    J Nucl Med; 2008 Jun; 49(6):1017-23. PubMed ID: 18483099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications, sequela and dosimetry of iodine-131 therapy for thyroid carcinoma.
    Bushnell DL; Boles MA; Kaufman GE; Wadas MA; Barnes WE
    J Nucl Med; 1992 Dec; 33(12):2214-21. PubMed ID: 1460519
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of stunning of lung and bone metastases of papillary thyroid cancer after a therapeutic dose (3.7 GBq) of 131I and review of the literature: implications for sequential treatments.
    Leger AF; Pellan M; Dagousset F; Chevalier A; Keller I; Clerc J
    Br J Radiol; 2005 May; 78(929):428-32. PubMed ID: 15845937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone marrow depression due to 131I treatment of thyroid cancer].
    Keldsen N; Mortensen BT; Hansen HS
    Ugeskr Laeger; 1988 Nov; 150(46):2817-9. PubMed ID: 3206692
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of dialysis on 131I kinetics and dosimetry in thyroid cancer patients--a pharmacokinetic model.
    Pahlka RB; Sonnad JR
    Health Phys; 2006 Sep; 91(3):227-37. PubMed ID: 16891898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioiodine treatment in differentiated thyroid carcinomas. Treatment of first local recurrences and of bone and lung metastases.
    Charbord P; L'Heritier C; Cukersztein W; Lumbroso J; Tubiana M
    Ann Radiol (Paris); 1977; 20(8):783-6. PubMed ID: 610550
    [No Abstract]   [Full Text] [Related]  

  • 16. Metastatic differentiated carcinoma of the thyroid and radioiodine.
    Andrews JT; McGennisken MR
    Australas Radiol; 1987 Feb; 31(1):41-6. PubMed ID: 3619809
    [No Abstract]   [Full Text] [Related]  

  • 17. The changes in the thyroid gland after irradiation with 131I or partial thyroidectomy for thyrotoxicosis.
    Kennedy JS; Thomson JA
    J Pathol; 1974 Feb; 112(2):65-81. PubMed ID: 4834051
    [No Abstract]   [Full Text] [Related]  

  • 18. [Radioiodine therapy for lung and bone metastasis of differentiated thyroid cancer].
    Inagaki T; Shibata T; Iida Y; Kasagi K; Endo K; Konishi J; Torizuka K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Mar; 45(3):518-24. PubMed ID: 4011426
    [No Abstract]   [Full Text] [Related]  

  • 19. Pulmonary metastasis of differentiated thyroid carcinoma: treatment results in 101 patients.
    Samaan NA; Schultz PN; Haynie TP; Ordonez NG
    J Clin Endocrinol Metab; 1985 Feb; 60(2):376-80. PubMed ID: 3965495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radiation therapy of remote metastases from thyroid cancer].
    Kiseleva ES; Falileeva EP
    Med Radiol (Mosk); 1971 Feb; 16(2):27-37. PubMed ID: 5173489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.